NCT02297451

Brief Summary

Background: Arteriovenous fistula (AVF) is a form of vascular access for haemodialysis. An AVF is normally created at the level of the wrist, but occasionally it is created in the elbow when there is no suitable vessel in the forearm. The most common type of elbow (antecubital) fistula (AFF) is a brachiocephalic fistula, which carries significantly higher risk of steal syndrome (AVF-associated hand ischaemia) than wrist fistulas. More recently, AFF using proximal radial or ulnar artery as inflow has been described and shown to have a lower rate of Steal syndrome than brachiocephalic fistula. This study aims to investigate the incidence of steal syndrome between AFF using brachial artery and that using the proximal radial/ulnar artery as inflow.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2011

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

October 29, 2014

Completed
23 days until next milestone

First Posted

Study publicly available on registry

November 21, 2014

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

January 9, 2020

Status Verified

January 1, 2020

Enrollment Period

7.8 years

First QC Date

October 29, 2014

Last Update Submit

January 7, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of steal syndrome as measured by Hoek Score

    Determine the incidence of steal syndrome in the 2 arms of the study

    6 months

Secondary Outcomes (3)

  • Presence of severe steal syndrome necessitating surgical revision/ligation

    6 months

  • Operative time

    6 months

  • Utilisation of fistula

    6 months

Study Arms (2)

Brachial artery inflow

NO INTERVENTION

Elbow fistula created with brachial artery as inflow (ie. either brachiocephalic or brachiobasilic fistulas)

Proximal radial/ulnar artery as inflow

ACTIVE COMPARATOR

Elbow fistula created with either proximal radial or ulnar artery as inflow

Procedure: Proximal radial/ulnar artery as inflow

Interventions

Proximal radial/ulnar artery used as inflow

Proximal radial/ulnar artery as inflow

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • End stage renal failure Requiring AVF at in the antecubital fossa for haemodialysis

You may not qualify if:

  • When the participant has not received the allocated intervention due to anatomical anomaly, technical issue or any other reason

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Addenbrooke's Hospital

Cambridge, CB2 0QQ, United Kingdom

Location

MeSH Terms

Conditions

Arteriovenous FistulaKidney Failure, Chronic

Condition Hierarchy (Ancestors)

Arteriovenous MalformationsVascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular FistulaVascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsRenal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic Processes

Study Officials

  • Gavin Pettigrew, MD, FRCS

    University of Cambridge

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Research Fellow

Study Record Dates

First Submitted

October 29, 2014

First Posted

November 21, 2014

Study Start

February 1, 2011

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

January 9, 2020

Record last verified: 2020-01

Locations